How drugmakers became masters at producing authorized generics

When PDL BioPharma’s $40 million blood-pressure medicine faced the threat of a generic rival this year, the company pulled out a little-known strategy that critics say helps keep drugs expensive and competition weak. It launched its own generic version of Tekturna, a pill taken daily by thousands. PDL’s “authorized” copycat hit the market in March, […]

Find jobs at Careers by KevinMD.comSearch thousands of physician, PA, NP, and CRNA jobs now. Learn more.


Read the full post on KevinMD.com